Cargando…
PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD...
Autores principales: | Tzeng, Horng-Tay, Tsai, Hwei-Fang, Liao, Hsiu-Jung, Lin, Yi-Jiun, Chen, Lieping, Chen, Pei-Jer, Hsu, Ping-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382233/ https://www.ncbi.nlm.nih.gov/pubmed/22761734 http://dx.doi.org/10.1371/journal.pone.0039179 |
Ejemplares similares
-
Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2014) -
BLOCKAGE OF AMYLOID INDUCTION BY COLCHICINE IN AN ANIMAL MODEL
por: Shirahama, Tsuranobu, et al.
Publicado: (1974) -
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
por: Wang, Xueping, et al.
Publicado: (2020) -
Sugammadex for reversing neuromuscular blockages after lung surgery: A systematic review and meta-analysis
por: Yang, Jia-Li, et al.
Publicado: (2022) -
Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)